Company: VRCA
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0001193125-25-079118
Chunk: 2

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 2
---
STANDING EQUITY AWARDS AS OF DECEMBER 31, 2024                                                                                                                                                                          |     |      |  36 |
| NARRATIVE TO SUMMARY COMPENSATION TABLE                                                                                                                                                                                    |     |      |  37 |
| EQUITY-BASED AWARDS                                                                                                                                                                                                        |     |      |  39 |
| EMPLOYMENT ARRANGEMENTS AND POTENTIAL PAYMENTS UPON TERMINATION OF EMPLOYMENT OR CHANGE IN CONTROL                                                                                                                         |     |      |  39 |
| RETIREMENT BENEFITS AND OTHER COMPENSATION                                                                                                                                                                                 |     |      |  41 |
| PAY VERSUS PERFORMANCE                                                                                                                                                                                                     |     |      |  42 |
| DIRECTOR COMPENSATION                                                                                                                                                                                                      |     |      |  46 |
| NON-EMPLOYEE DIRECTOR COMPENSATION POLICY                                                                                                                                                                                  |     |      |  46 |
| POLICIES AND PRACTICES RELATED TO THE GRANT OF CERTAIN EQUITY AWARDS                                                                                                                                                       |     |      |  48 |
| SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS                                                                                                                                                         |     |      |  49 |
| TRANSACTIONS WITH RELATED PERSONS                                                                                                                                                                                          |     |      |  50 |
| RELATED-PERSON TRANSACTIONS POLICY AND PROCEDURES                                                                                                                                                                          |     |      |  50 |
| CERTAIN RELATED PARTY TRANSACTIONS                                                                                                                                                                                         |     |      |  50 |
| HOUSEHOLDING OF PROXY MATERIALS                                                                                                                                                                                            |     |      |  52 |
| OTHER MATTERS                                                                                                                                                                                                              |     |      |  52 |
| APPENDIX A - CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION                                                                                                                                 |     |      | A-1 |

i

<div align='center'>**VERRICA PHARMACEUTICALS INC.

44 W. Gay St., Suite 400

West Chester, Pennsylvania 19380

PROXY STATEMENT

FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS

To Be Held on June 5, 2025

QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING**</div>

**Why did I receive a notice regarding the availability of proxy materials on the internet?

Pursuant to rules adopted by the Securities and Exchange Commission (the “SEC”), we have elected to provide access to our